Momenimovahed Zohre, Taheri Safoura, Tiznobaik Azita, Salehiniya Hamid
Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Qom University of Medical Sciences, Qom, Iran.
Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran.
Front Endocrinol (Lausanne). 2019 May 24;10:313. doi: 10.3389/fendo.2019.00313. eCollection 2019.
All over the world, many couples cannot conceive a child and have problems with pregnancy. Ovulation-inducing drugs are among the most important drugs used for the treatment of infertility. In recent years, there have been many debates about the relationship between fertility medication and cancer. Due to the lack of comprehensive study of this matter, and as understanding the relationship between the use of fertility drugs and cancer is of importance, the present study was conducted to investigate the relationship between infertility drugs and cancer in women. To determine the relationship between infertility treatment and cancer, a comprehensive search was carried out in databases such as; Medline, Web of Science Core Collection, and Scopus using keywords words; "infertility," "ovulation induction," "cancer," "infertility treatment," "ART," "tumor," "controlled ovarian stimulation," "fertility agents," and "neoplasms." Full-text, English language, and original articles were included in this study. In total, 81 articles were entered into the study. The relationship between fertility medications and breast, ovary, endometrial, uterus, colon, thyroid, skin, cervical, and non-Hodgkin's lymphoma cancers were studied. Although the relationship between fertility medications and cancer is theoretically justifiable, most studies have shown that risk of cancer will not increase after fertility treatment. The results of this study did not show that fertility medications increase the risk of cancer among users. In summary, the relationship between infertility treatment and cancer incidence remains an open question.
在世界各地,许多夫妇无法受孕且存在妊娠问题。促排卵药物是治疗不孕症最重要的药物之一。近年来,关于生育药物与癌症之间的关系存在诸多争论。由于对此问题缺乏全面研究,且鉴于了解生育药物的使用与癌症之间的关系至关重要,本研究旨在调查女性不孕症药物与癌症之间的关系。为确定不孕症治疗与癌症之间的关系,在诸如Medline、科学引文索引核心合集和Scopus等数据库中使用关键词“不孕症”“促排卵”“癌症”“不孕症治疗”“辅助生殖技术”“肿瘤”“控制性卵巢刺激”“生育药物”和“肿瘤”进行了全面检索。本研究纳入了全文、英文和原创文章。总共81篇文章进入该研究。研究了生育药物与乳腺癌、卵巢癌、子宫内膜癌、子宫癌、结肠癌、甲状腺癌、皮肤癌、宫颈癌和非霍奇金淋巴瘤之间的关系。尽管生育药物与癌症之间的关系在理论上是合理的,但大多数研究表明,生育治疗后癌症风险不会增加。本研究结果并未表明生育药物会增加使用者患癌风险。总之,不孕症治疗与癌症发病率之间的关系仍是一个悬而未决的问题。